Concord Biotech Limited — Important, 29-05-2025: General Updates

Concord Biotech reported consolidated revenue of Rs. 1200.09 Cr, up from Rs. 1016.94 Cr, with profit after tax rising 20.6% to Rs. 371.64 Cr. A dividend of Rs. 10.70 per share has been proposed. Operationally, Ms. Hina Patel joins as Company Secretary, alongside new secretarial, internal, and cost auditors, indicating strengthened corporate governance.